🇺🇸 FDA
Patent

US 11045522

Glucagon-like peptide 1 receptor agonists and uses thereof

granted A61KA61K31/155A61K31/5415

Quick answer

US patent 11045522 (Glucagon-like peptide 1 receptor agonists and uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jun 24 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Jun 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 24 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/155, A61K31/5415, A61K38/00, A61K38/26